These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6206185)

  • 1. Analysis of T cell populations that induce and mediate specific resistance to graft-versus-host disease in rats.
    Kimura H; Pickard A; Wilson DB
    J Exp Med; 1984 Sep; 160(3):652-8. PubMed ID: 6206185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPECIFIC positive and negative selection of rat lymphocytes reactive to strong histocompatibility antigens: activation with alloantigens in vitro and in vivo.
    Wilson DB; Marshak A; Howard JC
    J Immunol; 1976 Apr; 116(4):1030-40. PubMed ID: 56402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M; Sharrow SO; Shearer GM
    J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-idiotypic cytotoxic T cells in rats with graft-versus-host disease.
    Kimura H; Wilson DB
    Nature; 1984 Mar 29-Apr 4; 308(5958):463-4. PubMed ID: 6608695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
    Fischer AC; Laulis MK; Horwitz L; Beschorner WE; Hess A
    J Immunol; 1989 Aug; 143(3):827-32. PubMed ID: 2526175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies of T-cell receptors. I. Specifically induced resistance to graft-versus-host disease in rats mediated by host T-cell immunity to alloreactive parental T cells.
    Bellgrau D; Wilson DB
    J Exp Med; 1978 Jul; 148(1):103-14. PubMed ID: 78954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of specific resistance in F1 hybrid rats to local graft-vs.-host reactions: nature of the eliciting cell.
    Woodland RT; Wilson DB
    Eur J Immunol; 1977 Mar; 7(3):136-42. PubMed ID: 67953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases.
    Gleichmann E; Gleichmann H
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):115s-120s. PubMed ID: 3159804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease.
    Ghayur T; Seemayer TA; Kongshavn PA; Gartner JG; Lapp WS
    Transplantation; 1987 Aug; 44(2):261-7. PubMed ID: 3307050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.
    Pals ST; Gleichmann H; Gleichmann E
    J Exp Med; 1984 Feb; 159(2):508-23. PubMed ID: 6229596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced tolerance in F1 rats to anti-major histocompatibility complex receptors on parental T cells. Implications for self tolerance.
    Bellgrau D; Smilek D; Wilson DB
    J Exp Med; 1981 Jun; 153(6):1660-5. PubMed ID: 6973003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. W3/25+ T cells mediate the induction of immunologic unresponsiveness in enhanced rat recipients of cardiac allografts.
    Padberg WM; Kupiec-Weglinski JW; Lord RH; Araneda DH; Tilney NL
    J Immunol; 1987 Jun; 138(11):3669-74. PubMed ID: 2953786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. I. Demonstration of similar or identical idiotypes on IgG molecules and T-cell receptors with specificity for the same alloantigens.
    Binz H; Wigzell H
    J Exp Med; 1975 Jul; 142(1):197-211. PubMed ID: 50400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The host response in graft versus host disease. I. Radiosensitive T cells of host origin inhibit parental anti-F1 cytotoxicity in murine chronic graft versus host disease.
    Singh AB; Hiehle K; Singh M; Jetzt AE; O'Connell SM; Mann RA
    Cell Immunol; 1993 Oct; 151(1):24-38. PubMed ID: 8402929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.
    Van Elven EH; Rolink AG; Veen FV; Gleichmann E
    J Exp Med; 1981 Jun; 153(6):1474-88. PubMed ID: 6454750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological studies of T-cell receptors. II. Limited polymorphism of idiotypic determinants on T-cell receptors specific for major histocompatibility complex alloantigens.
    Bellgrau D; Wilson DB
    J Exp Med; 1979 Jan; 149(1):234-43. PubMed ID: 33224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
    Clerici M; Villa ML; Clerici E
    Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-host resistance induced by tolerant cell populations. Evidence against clonal deletion as a mechanism of transplantation tolerance.
    Wotherspoon JS; Dorsch SE
    Transplantation; 1989 Mar; 47(3):528-32. PubMed ID: 2922801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.